Durso Jerome Benedict's Form 4 filing
Altimmune, Inc. (ALT) · filed Aug 13, 2026
- Accession no.
- 0001698665-26-000007
- Filed
- Aug 13, 2026, 4:05 PM ET
- Trade date
- Aug 13, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $44.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Durso Jerome BenedictCIK 0001698665 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock, par value $0.0001 | PPurchaseAcquired | +15,000 | $2.95 | +$44,250 | 62,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.